The Targeted technology Funds are focused on investing in life science companies that have the opportunity to advance ground breaking or disruptive technologies and which have the potential to significantly improve the outcomes for patients with significant medical conditions. We also favor technologies that can greatly impact the efficiency, cost or functionality of the development and manufacture of life science products. We believe that our life science investment model is particularly suited to today's healthcare and economic environment that favors innovation which can improve clinical outcome and patient care and reduce healthcare budgets.
Targeted Technology
Venture CapitalThe Targeted technology Funds are focused on investing in life science companies that have the opportunity to advance ground breaking or disruptive technologies and which have the potential to significantly improve the outcomes for patients with significant medical conditions.
11
Total Investments
9
Portfolio Companies
-
Exits
1
Industries
General Information
Company Overview
Investment Criteria
•••••• •••••• ••••••
About Targeted Technology
Recent Investments (11)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed Round | •••••• | Nov 2017 | |
| Series B | •••••• | Jun 2017 | |
| Series A | •••••• | Feb 2016 | |
| Series A | •••••• | Apr 2015 | |
| Venture Round | •••••• | Jan 2015 | |
|
|
Series B | •••••• | Oct 2014 |
|
|
Series A | •••••• | Jul 2014 |
|
|
Venture Round | •••••• | Nov 2013 |
|
|
Series A | •••••• | Apr 2013 |
|
|
Series C | •••••• | Sep 2012 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.